SkinHealth Systems Inc. (Nasdaq: SKIN) is a special purpose acquisition company focused on the healthcare and dermatology sector. The company filed a Form DEFA14A — additional definitive proxy solicitation materials — with the SEC on August 12, 2026 (accession no. 0001683168-26-006276), indicating it is in an active shareholder solicitation process, most likely related to a proposed business combination or extension of its SPAC deadline. DEFA14A filings typically accompany previously distributed proxy statements and are used to provide supplemental information to shareholders ahead of a vote. SkinHealth Systems targets the growing medical aesthetics and dermatological services market, a sector that has attracted sustained SPAC interest in recent years. For the full filing history, sponsor details, trust data, and deal timeline for SKIN, create a free account at SpacDesk.